Search for…

• Cyclopeptides for treating amyloid diseases and their comorbidities

  B85108

  Cyclopeptides for treating amyloid diseases and their comorbidities

  • Strong binding to Aβ42 (AD), IAPP (T2D) and αSyn (PD)
  • Act at nanomolar to low micromolar concentrations and cheap to synthesize
  • Highly soluble, non-amyloidogenic, and non-toxic
• Multifunctional Anti-Amyloid Peptides

  B84076

  Multifunctional Anti-Amyloid Peptides

  • MCIPs as candidates for treatment of PD, AD and T2D
  • Proteolytic stability in human plasma and effective crossing of human blood brain barrier
  • Promising in vivo data ongoing
• Tau aggregation inhibiting peptides as a basis for future therapies for tauopathies

  B79054

  Tau aggregation inhibiting peptides as a basis for future therapies for tauopathies

  • Tau aggregation inhibiting peptides
  • Strongly bind to tau monomers, -oligomers and -fibrils
  • Suitable for future tauopathy therapies

3 of 96 Tech Offers